Key facts
- It has raised $114.8M; the latest was Later Stage VC ($114.8M) in Feb 2026.
- Notable investors include Legend Capital, Guoxing Capital, Xiamen International Trade Group.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Guoke Ion
- ·The full record, as it builds
Funding rounds
No funding rounds for Guoke Ion are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Guoke Ion
Manufacturer of ion therapy medical equipment designed to advance precision cancer diagnosis and treatment through particle radiation technology. The company offers heavy ion and light ion accelerator systems, integrated digital medical platforms, and lifecycle operation and maintenance services, enabling hospitals and oncology treatment centres to deliver accurate tumour therapy with reduced infrastructure burden and improved clinical accessibility.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2018
- Employees
- 7
- Website
- cashim.com.cn/
- Ownership
- Privately Held (backing)
Guoke Ion doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Guoke Ion shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Guoke Ion in its N-PORT filings yet. We sweep new filings monthly.